Predictability of human pharmacokinetics of drugs that undergo hepatic organic anion transporting polypeptide (OATP)-mediated transport using single-species allometric scaling in chimeric mice with humanized liver: integration with hepatic drug metabolism

References

• Adachi K, Suemizu H, Murayama N, et al. (2015). Human biofluid concentrations of mono(2-ethylhexyl)phthalate extrapolated from pharmacokinetics in chimeric mice with humanized liver administered with di(2-ethylhexyl)phthalate and physiologically based pharmacokinetic modeling. Environ Toxicol Pharmacol 39:1067–73.
   PubMed Web of Science ®Google Scholar
• Boxenbaum H, Ronfeld R. (1983). Interspecies pharmacokinetic scaling and the Dedrick plots. Am J Physiol 245:R768–75.
   PubMed Web of Science ®Google Scholar
• Chu X, Bleasby K, Evers R. (2013). Species differences in drug transporters and implications for translating preclinical findings to humans. Expert Opin Drug Metab Toxicol 9:237–52.
   PubMed Web of Science ®Google Scholar
• De Bruyn T, Ufuk A, Cantrill C, et al. (2018). Predicting human clearance of organic anion transporting polypeptide substrates using cynomolgus monkey: In vitro-in vivo scaling of hepatic uptake clearance. Drug Metab Dispos 46:989–1000.
   PubMed Web of Science ®Google Scholar
• Dedrick R, Bischoff KB, Zaharko DS. (1970). Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother Rep 54:95–101.
   PubMedGoogle Scholar
• Durmus S, van Hoppe S, Schinkel AH. (2016). The impact of Organic Anion-Transporting Polypeptides (OATPs) on disposition and toxicity of antitumor drugs: Insights from knockout and humanized mice. Drug Resist Updat 27:72–88.
   PubMed Web of Science ®Google Scholar
• Fujino R, Hashizume K, Aoyama S, et al. (2018). Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake. Eur J Pharm Sci 125:181–92.
   PubMed Web of Science ®Google Scholar
• Fujino H, Kojima J, Yamada Y, et al. (1999). Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (4): Interspecies variation in laboratory animals and humans. Xenobio Metabol Dispos 14:79–91.
   Google Scholar
• Grompe M, Strom S. (2013). Mice with human livers. Gastroenterology 145:1209–14.
   PubMed Web of Science ®Google Scholar
• Heizmann P, Eckert M, Ziegler WH. (1983). Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol 16 Suppl 1:43S–9S.
   PubMed Web of Science ®Google Scholar
• Higgins JW, Bao JQ, Ke AB, et al. (2014). Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein. Drug Metab Dispos 42:182–92.
   PubMed Web of Science ®Google Scholar
• Hirano M, Maeda K, Shitara Y, Sugiyama Y. (2004). Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. J Pharmacol Exp Ther 311:139–46.
   PubMed Web of Science ®Google Scholar
• Hornberg JJ, Laursen M, Brenden N, et al. (2014). Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how. Drug Discov Today 19:1131–6.
   PubMed Web of Science ®Google Scholar
• Hosea NA, Collard WT, Cole S, et al. (2009). Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches. J Clin Pharmacol 49:513–33.
   PubMed Web of Science ®Google Scholar
• Izumi S, Nozaki Y, Komori T, et al. (2017). Comparison of the predictability of human hepatic clearance for organic anion transporting polypeptide substrate drugs between different in vitro-in vivo extrapolation approaches. J Pharm Sci 106:2678–87.
   PubMed Web of Science ®Google Scholar
• Izumi S, Nozaki Y, Kusuhara H, et al. (2018). Relative activity factor (RAF)-based scaling of uptake clearance mediated by organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 in human hepatocytes. Mol Pharm 15:2277–88.
   PubMed Web of Science ®Google Scholar
• Jones HM, Barton HA, Lai Y, et al. (2012). Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data. Drug Metab Dispos 40:1007–17.
   PubMed Web of Science ®Google Scholar
• Kalliokoski A, Niemi M. (2009). Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 158:693–705.
   PubMed Web of Science ®Google Scholar
• Kamimura H, Ito S, Chijiwa H, et al. (2017). Simulation of human plasma concentration-time profiles of the partial glucokinase activator PF-04937319 and its disproportionate N-demethylated metabolite using humanized chimeric mice and semi-physiological pharmacokinetic modeling. Xenobiotica 47:382–93.
   PubMed Web of Science ®Google Scholar
• Karibe T, Hagihara-Nakagomi R, Abe K, et al. (2015). Evaluation of the usefulness of breast cancer resistance protein (BCRP) knockout mice and BCRP inhibitor-treated monkeys to estimate the clinical impact of BCRP modulation on the pharmacokinetics of BCRP substrates. Pharm Res 32:1634–47.
   PubMed Web of Science ®Google Scholar
• Kimata H, Fujino H, Koide T, et al. (1998). Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (1): absorption, distribution, metabolism and excretion in rats. Xenobio Metabol Dispos 13:484–98.
   Google Scholar
• Kunze A, Huwyler J, Camenisch G, Poller B. (2014). Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data. Drug Metab Dispos 42:1514–21.
   PubMed Web of Science ®Google Scholar
• Martin W, Koselowske G, Töberich H, et al. (1990). Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man. Biopharm Drug Dispos 11:265–78.
   PubMed Web of Science ®Google Scholar
• Matsunaga N, Ufuk A, Morse BL, et al. (2019). Hepatic organic anion transporting polypeptide-mediated clearance in the beagle dog: Assessing in vitro-in vivo relationships and applying cross-species empirical scaling factors to improve prediction of human clearance. Drug Metab Dispos 47:215–26.
   PubMed Web of Science ®Google Scholar
• Ménochet K, Kenworthy KE, Houston JB, Galetin A. (2012). Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes. Drug Metab Dispos 40:1744–56.
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Iwasaki S, Chisaki I, et al. (2017). Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver. Xenobiotica 47:1052–63.
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Iwasaki S, Chisaki I, et al. (2019). Prediction of human pharmacokinetics of long half-life compounds using chimeric mice with humanised liver. Xenobiotica 49:1379–87.
   PubMed Web of Science ®Google Scholar
• Nakashima M, Uematsu T, Kanemaru M. (1992). Phase I study of AT-877 (Fasudil hydrochloride) in healthy subjects: single and multiple administration. Jpn Pharmacol Ther 20:S1559–S85.
   Google Scholar
• Nakayama K, Ito S, Suzuki M, et al. (2019). Prediction of human pharmacokinetics of typical compounds by a physiologically based method using chimeric mice with humanized liver. Xenobiotica 49:404–14.
   PubMed Web of Science ®Google Scholar
• Naritomi Y, Sanoh S, Ohta S. (2018). Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery. Drug Metab Pharmacokinet 33:31–9.
   PubMed Web of Science ®Google Scholar
• Naritomi Y, Sanoh S, Ohta S. (2019). Utility of chimeric mice with humanized liver for predicting human pharmacokinetics in drug discovery: Comparison with in vitro-in vivo extrapolation and allometric scaling. Biol Pharm Bull 42:327–36.
   PubMed Web of Science ®Google Scholar
• Obach RS, Baxter JG, Liston TE, et al. (1997). The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J Pharmacol Exp Ther 283:46–58.
   PubMed Web of Science ®Google Scholar
• Obach RS, Lombardo F, Waters NJ. (2008). Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos 36:1385–405.
   PubMed Web of Science ®Google Scholar
• Ohtsuki S, Kawakami H, Inoue T, et al. (2014). Validation of uPA/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS/MS. Drug Metab Dispos 42:1039–43.
   PubMed Web of Science ®Google Scholar
• Pieters FA, Zuidema J. (1987). The absolute oral bioavailability of dapsone in dogs and humans. Int J Clin Pharmacol Ther Toxicol 25:396–400.
   PubMed Web of Science ®Google Scholar
• Salphati L, Chu X, Chen L, et al. (2014). Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins. Drug Metab Dispos 42:1301–13.
   PubMed Web of Science ®Google Scholar
• Sanoh S, Horiguchi A, Sugihara K, et al. (2012). Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver. Drug Metab Dispos 40:322–8.
   PubMed Web of Science ®Google Scholar
• Sanoh S, Naritomi Y, Fujimoto M, et al. (2015). Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liver. Xenobiotica 45:605–14.
   PubMed Web of Science ®Google Scholar
• Scheer N, Wilson ID. (2016). A comparison between genetically humanized and chimeric liver humanized mouse models for studies in drug metabolism and toxicity. Drug Discov Today 21:250–63.
   PubMed Web of Science ®Google Scholar
• Shitara Y, Horie T, Sugiyama Y. (2006). Transporters as a determinant of drug clearance and tissue distribution. Eur J Pharm Sci 27:425–46.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Uno Y, Yamazaki H, Kume T. (2019). Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes. Biopharm Drug Dispos 40:62–9.
   PubMed Web of Science ®Google Scholar
• Takaoka N, Sanoh S, Okuda K, et al. (2018). Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions. Biochem Pharmacol 154:28–38.
   PubMed Web of Science ®Google Scholar
• Takehara I, Watanabe N, Mori D, et al. (2019). Effect of rifampicin on the plasma concentrations of bile acid-O-sulfates in monkeys and human liver-transplanted chimeric mice with or without bile flow diversion. J Pharm Sci 108:2756–64.
   PubMed Web of Science ®Google Scholar
• Tateno C, Kawase Y, Tobita Y, et al. (2015). Generation of novel chimeric mice with humanized livers by using hemizygous cDNA-uPA/SCID mice. PLoS One 10:e0142145.
   PubMed Web of Science ®Google Scholar
• Uchida M, Tajima Y, Kakuni M, et al. (2018). Organic anion-transporting polypeptide (OATP)-mediated drug-drug interaction study between rosuvastatin and cyclosporine A in chimeric mice with humanized liver. Drug Metab Dispos 46:11–9.
   PubMed Web of Science ®Google Scholar
• van de Steeg E, van Esch A, Wagenaar E, et al. (2013). Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice. Clin Cancer Res 19:821–32.
   PubMed Web of Science ®Google Scholar
• Wang L, Prasad B, Salphati L, et al. (2015). Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics. Drug Metab Dispos 43:367–74.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Kusuhara H, Maeda K, et al. (2010). Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans. Drug Metab Dispos 38:215–22.
   PubMed Web of Science ®Google Scholar
• Willis JV, Kendall MJ, Flinn RM, et al. (1979). The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol 16:405–10.
   PubMed Web of Science ®Google Scholar